Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWhitbread Regulatory News (WTB)

Share Price Information for Whitbread (WTB)

Share Price is delayed by 15 minutes
Get Live Data
2,340.00    1.00 (0.04%)
Bid:
2,342.00
Ask:
2,344.00
Spread: 2.00 (0.085%)
Market Cap: £3.91b
WTB Live PriceLast checked at - London Stock Exchange

Intraday Whitbread Share Chart

Share Repurchase Programme

1 May 2025 07:05

RNS Number : 9278G
Whitbread PLC
01 May 2025
 

 

SHARE REPURCHASE PROGRAMME

 

As announced in today's full year preliminary results announcement, Whitbread PLC ('Whitbread' or the 'Company') is commencing a share buy-back programme of up to a maximum consideration of £250 million (the 'Programme'). The purpose of the Programme is to reduce the capital of Whitbread by returning surplus capital to shareholders and it is expected that the implementation of the Programme will enhance earnings per share. Whitbread has instructed Morgan Stanley & Co International Plc ('Morgan Stanley') to execute the Programme.

 

Whitbread has entered into a non-discretionary and irrevocable instruction with Morgan Stanley in relation to the purchase by Morgan Stanley, acting as riskless principal during the period commencing today and ending no later than 30 April 2026, of the Company's Ordinary Shares of 76 122/153 pence each ('Ordinary Shares') for an aggregate purchase price of up to but not greater than £250 million.

 

Morgan Stanley shall make a simultaneous on-sale of Ordinary Shares purchased under the instruction to Whitbread. Morgan Stanley will make its trading decisions in relation to the Programme independently of, and uninfluenced by, Whitbread.

 

Prior to the Company's Annual General Meeting scheduled to be held on 19 June 2025 (the '2025 AGM') the maximum number of Ordinary Shares that can be purchased under the Programme is 13,250,263 Ordinary Shares (based on authority granted at the Company's Annual General Meeting held on 18 June 2024 (the '2024 AGM')). This existing authority to buy back shares granted at the 2024 AGM expires at the conclusion of the 2025 AGM (or, if earlier, 18 September 2025). The continuation of the Programme after the 2025 AGM is subject to purchases of Shares pursuant to the Programme remaining within the shareholder authority (if any) for the Company to purchase its Shares that is granted at the 2025 AGM.

 

Any purchase of Ordinary Shares made by Morgan Stanley in relation to the Programme will be carried out on the London Stock Exchange plc, Cboe Europe Limited or Aquis Stock Exchange Limited. The buy-back by Whitbread will be executed in accordance with the UK Listing Rules and Whitbread's general authority (from time to time) to make market purchases of Ordinary Shares. The Programme will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014, the Commission Delegated Regulation (EU) 2016/1052 (both as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and with regard to regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation measures. Whitbread will announce any purchase by it of Ordinary Shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred. Ordinary Shares purchased under the Programme will be cancelled or (to the extent permitted by law) held in treasury.

 

Morgan Stanley may undertake transactions in shares (which may include sales and hedging activities, in addition to purchases which may take place on any available trading venue or on an over the counter basis) during the period of the Programme in order to manage their market exposure under the Programme. Disclosure of such transactions will not be made by Morgan Stanley as a result of or as part of the Programme, but Morgan Stanley will continue to make any disclosures they are otherwise legally required to make.

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

For more information please contact:

Investor Relations - Whitbread investorrelations@whitbread.com

Media - Brunswick Whitbread@brunswickgroup.com

Tim Danaher +44 (0) 20 7404 5959

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAXLEDDFSEFA
Date   Source Headline
29th Jun 202210:15 amRNSDirectorate Change
17th Jun 20223:56 pmRNSHolding(s) in Company
15th Jun 20225:24 pmRNSResult of AGM
15th Jun 20227:00 amRNSQ1 Trading Update
10th Jun 20229:59 amRNSHolding(s) in Company
1st Jun 20224:52 pmRNSTotal Voting Rights
27th May 20224:33 pmRNSDirector/PDMR Shareholding
24th May 20224:08 pmRNSDirector/PDMR Shareholding
13th May 20221:39 pmRNSDirector/PDMR Shareholding
12th May 20224:57 pmRNSNotice of AGM
28th Apr 20224:02 pmRNSDirector/PDMR Shareholding
28th Apr 20227:00 amRNSPreliminary Results Announcement
1st Apr 202212:40 pmRNSTotal Voting Rights
7th Mar 20223:57 pmRNSDirector/PDMR Shareholding
2nd Mar 20222:46 pmRNSTotal Voting Rights
1st Feb 20229:11 amRNSTotal Voting Rights
27th Jan 20227:00 amRNSDirectorate Change
25th Jan 20229:57 amRNSBlock listing Interim Review
12th Jan 20227:00 amRNSQ3 FY22 Trading Update
4th Jan 20229:08 amRNSTotal Voting Rights
23rd Dec 202111:34 amRNSDirector/PDMR Shareholding
17th Dec 20214:59 pmRNSAGM Statement
1st Dec 202110:01 amRNSTotal Voting Rights
23rd Nov 20213:31 pmRNSDirector/PDMR Shareholding
8th Nov 20211:18 pmRNSDirector/PDMR Shareholding
1st Nov 20213:14 pmRNSTotal Voting Rights
28th Oct 20214:40 pmRNSDirector/PDMR Shareholding
28th Oct 20213:45 pmRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSWhitbread Interim Results
15th Oct 202112:15 pmRNSDirectorate Change
1st Oct 202110:07 amRNSTotal Voting Rights
1st Sep 20214:45 pmRNSS430 (2B) Companies Act 2006 Statement
1st Sep 20214:41 pmRNSTotal Voting Rights
17th Aug 20217:48 amRNSDirector Declaration
11th Aug 20214:28 pmRNSDirector/PDMR Shareholding
9th Aug 20214:32 pmRNSDirector/PDMR Shareholding
6th Aug 20219:56 amRNSTotal Voting Rights
2nd Aug 20213:20 pmRNSDirector/PDMR Shareholding
26th Jul 20219:17 amRNSBlock listing Interim Review
1st Jul 20213:55 pmRNSDirector/PDMR Shareholding
1st Jul 20213:52 pmRNSTotal Voting Rights
25th Jun 202111:54 amRNSDirector/PDMR Shareholding
18th Jun 202112:09 pmRNSDirector/PDMR Shareholding
17th Jun 20214:36 pmRNSAGM Statement
17th Jun 20217:00 amRNSQ1 FY22 Trading Update
4th Jun 20213:33 pmRNSWhitbread PLC - AGM arrangements
1st Jun 20214:58 pmRNSTotal Voting Rights
12th May 20212:07 pmRNSDirector/PDMR Shareholding
7th May 20215:00 pmRNSAnnual Financial Report
7th May 20214:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.